Cambridge Epigenetix raised €19M in a Series B round in Mar 2016. The company is based in Cambridge, UK. Investors in the round: GV (Google Ventures), New Science Ventures, Sequoia Capital and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
